Another study confirms the efficacy of cannabidiol in the treatment of multiple sclerosis.

Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system. More recently, researchers at the Kajal Institute have confirmed that Cannabidiol not only reduces the inflammatory effects of multiple sclerosis, but can also protect you from the disease for a long time. CBD oil was used to treat mice with multiple sclerosis for ten days. Those who were given CBD oil had better success and motor skills than those who were not treated. Based on this study, scientists conclude that cannabidiol has the potential to reduce the negative effects of multiple sclerosis.

Thanks to the many undeniable results of research demonstrating the efficacy of the use of SBD drugs in the treatment of this disease, the combination of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracted from cannabis has recently been approved in many parts of the world for the treatment of spasticity associated with multiple sclerosis.

Today, another study was published that proves that combined therapy of THC + SBD (10 mg/kg each) weakens the experimental mouse autoimmune encephalitis, reducing the neuroinflammation and suppression of Th17 and Th1 cells. Besides, the study showed that the combination of THC + CBD suppresses neuroinflammation. We suggest that you read the study here.